Symposium | Future perspectives for cytopenic MF: Panel discussion and Q&A

At the European School of Haematology (ESH) 11th Translational Research Conference: Myeloproliferative Neoplasms, Apr 24–26, 2026, Estoril, PT, the MPN Hub held a symposium, titled Patient-centered approaches in myelofibrosis: Tailoring treatment for anemia and thrombocytopenia. During the symposium, MPN Hub Steering Committee Chair Jean-Jacques Kiladjian, Université Paris Cité - Hôpital Saint-Louis, Paris, FR, and Steering Committee members Steffen Koschmieder, Uniklinik RWTH Aachen, DE, and Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discussed future perspectives for cytopenic myelofibrosis (MF) during a panel discussion and Q&A session. 

In this presentation, Kiladjian, Koschmieder, and Harrison discuss practical approaches to the management of cytopenias in myelofibrosis, including treatment selection, management of treatment-emergent anemia, supportive care strategies, and future directions for individualized and combination therapies. 

This educational resource is independently supported by GSK. All content is developed by the faculty in collaboration with SES. Funders are allowed no influence. 

Hosted on Acast. See acast.com/privacy for more information.